Practice Area Focus
- Development Strategy
- Regulatory Strategy
- Product Life Cycle Management
Dr. Young joined NDA Partners as a Premier Expert consultant in 2014. He provides strategic counsel and advice to pharmaceutical and biotechnology companies regarding FDA marketing approval and life cycle management. Dr. Young is currently General Counsel and Vice President of Policy/Advocacy for Braeburn Pharmaceuticals. He also continues to practice law through his own law firm, Breakthrough Counsel LLC. Previously he was Partner and General Counsel at FoxKiser, Chairman of the National Council on Disability (appointed by President Obama and confirmed by the US Senate), and Associate Director of the White House Office of Public Liaison under President Clinton. Dr. Young is widely recognized for his executive management skills in analyzing complex problems, identifying and articulating strategic solutions, assembling and leading teams to meet strategic objectives, and executing strategic plans.